Vascular Graft

Vascular Graft Comprehensive Study by Raw Material (Polyester, EPTFE, Polyurethane, Biosyntheti), Indication (EVAR (Abdominal Aneurysm Repair & Thoracic Aneurysm0, Peripheral Vascular Repair, Hemodialysis Access), End User (Hospital, Ambulatory Surgery Center) Players and Region - Global Market Outlook to 2030

Vascular Graft Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Vascular Graft
A vascular graft also is known as vascular bypass, is a surgical procedure that is performed to redirects blood flow from one area of the body to another by reconnecting the blood vessels. They are implanted in the patient with the blocked blood vessel in order to restore the normal flow of blood within the body. The vascular graft market is expected to rise owing to various factors such as the increase in hypertension, cardiovascular diseases and changing lifestyle as consumption of junk food, tobacco which leads to the blockage of blood vessels.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Vascular Graft market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

B. Braun (Germany), Medtronic (Ireland), C. R. Bard (United States), LeMaitre Vascular (United States), Cardinal Health (United States), Maquet (Germany), Cook Medical (United States), Endologix (United States), Gore Medical (United States) and Terumo (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Getinge Group, Bard, JUNKEN MEDICAL, Shanghai Suokang and Shanghai Chest Medical.

Segmentation Overview
AMA Research has segmented the market of Global Vascular Graft market by and Region.



On the basis of geography, the market of Vascular Graft has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Raw Material, the sub-segment i.e. Polyester will boost the Vascular Graft market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Indication, the sub-segment i.e. EVAR (Abdominal Aneurysm Repair & Thoracic Aneurysm0 will boost the Vascular Graft market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospital will boost the Vascular Graft market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Development of Biosynthetic Vascular Graft

Market Growth Drivers:
Growth in the Geriatric Population and the Associated Increase in the Prevalence of Aneurysm, Rising Occurrence of Diabetes, End-Stage Renal Disease, and Vascular Occlusion and Increasing Prevalence of Smoking

Challenges:
Dearth of Skilled Professionals in Developing Countries and Vascular Graft Infections

Restraints:
High Cost Associated with Vascular Graft Treatment, Product Failure and Recalls and Unfavorable Reimbursement Scenario

Opportunities:
Potential Growth in Emerging Countries and Increasing Awareness About the Vascular Grafts and Its Advantages

Market Leaders and their expansionary development strategies
In June 2020, LeMaitre Vascular, Inc. has acquired the business and assets of Artegraft, Inc. Under the terms of the deal, LeMaitre will continue to operate Artegraft’s manufacturing facility in North Brunswick, NJ for at least three and a half years and will retain most of Artegraft’s employees, including seven sales & marketing personnel.
In June 2023, Terumo Aortic announced in a press release the launch of the company’s global post-approval study (PAS) known as EXTEND for Thoraflex Hybrid, the only frozen elephant trunk (FET) device approved by the US Food and Drug Administration (FDA) for the treatment of patients with complex aortic arch disease.
The global population aged 60 years or over numbered 962 million in 2017. The number of older persons is expected to double again by 2050, when it is projected to reach nearly 2.1 billion.

Key Target Audience
Manufacturers and vendors of vascular grafts, Hospitals, Ambulatory surgical centers, Research associations related to vascular grafts, Various research and consulting firms, Distributors of vascular grafts, Vascular Surgeons, Cardiologists, Research institutes, Government bodies and Venture capitalists

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Raw Material
  • Polyester
  • EPTFE
  • Polyurethane
  • Biosyntheti

By Indication
  • EVAR (Abdominal Aneurysm Repair & Thoracic Aneurysm0
  • Peripheral Vascular Repair
  • Hemodialysis Access

By End User
  • Hospital
  • Ambulatory Surgery Center

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in the Geriatric Population and the Associated Increase in the Prevalence of Aneurysm
      • 3.2.2. Rising Occurrence of Diabetes, End-Stage Renal Disease, and Vascular Occlusion
      • 3.2.3. Increasing Prevalence of Smoking
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Professionals in Developing Countries
      • 3.3.2. Vascular Graft Infections
    • 3.4. Market Trends
      • 3.4.1. Development of Biosynthetic Vascular Graft
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Vascular Graft, by Raw Material, Indication, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Vascular Graft (Value)
      • 5.2.1. Global Vascular Graft by: Raw Material (Value)
        • 5.2.1.1. Polyester
        • 5.2.1.2. EPTFE
        • 5.2.1.3. Polyurethane
        • 5.2.1.4. Biosyntheti
      • 5.2.2. Global Vascular Graft by: Indication (Value)
        • 5.2.2.1. EVAR (Abdominal Aneurysm Repair & Thoracic Aneurysm0
        • 5.2.2.2. Peripheral Vascular Repair
        • 5.2.2.3. Hemodialysis Access
      • 5.2.3. Global Vascular Graft by: End User (Value)
        • 5.2.3.1. Hospital
        • 5.2.3.2. Ambulatory Surgery Center
      • 5.2.4. Global Vascular Graft Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Vascular Graft (Price)
  • 6. Vascular Graft: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. B. Braun (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. C. R. Bard (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. LeMaitre Vascular (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cardinal Health (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Maquet (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cook Medical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Endologix (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Gore Medical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Terumo (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Vascular Graft Sale, by Raw Material, Indication, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Vascular Graft (Value)
      • 7.2.1. Global Vascular Graft by: Raw Material (Value)
        • 7.2.1.1. Polyester
        • 7.2.1.2. EPTFE
        • 7.2.1.3. Polyurethane
        • 7.2.1.4. Biosyntheti
      • 7.2.2. Global Vascular Graft by: Indication (Value)
        • 7.2.2.1. EVAR (Abdominal Aneurysm Repair & Thoracic Aneurysm0
        • 7.2.2.2. Peripheral Vascular Repair
        • 7.2.2.3. Hemodialysis Access
      • 7.2.3. Global Vascular Graft by: End User (Value)
        • 7.2.3.1. Hospital
        • 7.2.3.2. Ambulatory Surgery Center
      • 7.2.4. Global Vascular Graft Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Vascular Graft (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Vascular Graft: by Raw Material(USD Million)
  • Table 2. Vascular Graft Polyester , by Region USD Million (2018-2023)
  • Table 3. Vascular Graft EPTFE , by Region USD Million (2018-2023)
  • Table 4. Vascular Graft Polyurethane , by Region USD Million (2018-2023)
  • Table 5. Vascular Graft Biosyntheti , by Region USD Million (2018-2023)
  • Table 6. Vascular Graft: by Indication(USD Million)
  • Table 7. Vascular Graft EVAR (Abdominal Aneurysm Repair & Thoracic Aneurysm0 , by Region USD Million (2018-2023)
  • Table 8. Vascular Graft Peripheral Vascular Repair , by Region USD Million (2018-2023)
  • Table 9. Vascular Graft Hemodialysis Access , by Region USD Million (2018-2023)
  • Table 10. Vascular Graft: by End User(USD Million)
  • Table 11. Vascular Graft Hospital , by Region USD Million (2018-2023)
  • Table 12. Vascular Graft Ambulatory Surgery Center , by Region USD Million (2018-2023)
  • Table 13. South America Vascular Graft, by Country USD Million (2018-2023)
  • Table 14. South America Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 15. South America Vascular Graft, by Indication USD Million (2018-2023)
  • Table 16. South America Vascular Graft, by End User USD Million (2018-2023)
  • Table 17. Brazil Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 18. Brazil Vascular Graft, by Indication USD Million (2018-2023)
  • Table 19. Brazil Vascular Graft, by End User USD Million (2018-2023)
  • Table 20. Argentina Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 21. Argentina Vascular Graft, by Indication USD Million (2018-2023)
  • Table 22. Argentina Vascular Graft, by End User USD Million (2018-2023)
  • Table 23. Rest of South America Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 24. Rest of South America Vascular Graft, by Indication USD Million (2018-2023)
  • Table 25. Rest of South America Vascular Graft, by End User USD Million (2018-2023)
  • Table 26. Asia Pacific Vascular Graft, by Country USD Million (2018-2023)
  • Table 27. Asia Pacific Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 28. Asia Pacific Vascular Graft, by Indication USD Million (2018-2023)
  • Table 29. Asia Pacific Vascular Graft, by End User USD Million (2018-2023)
  • Table 30. China Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 31. China Vascular Graft, by Indication USD Million (2018-2023)
  • Table 32. China Vascular Graft, by End User USD Million (2018-2023)
  • Table 33. Japan Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 34. Japan Vascular Graft, by Indication USD Million (2018-2023)
  • Table 35. Japan Vascular Graft, by End User USD Million (2018-2023)
  • Table 36. India Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 37. India Vascular Graft, by Indication USD Million (2018-2023)
  • Table 38. India Vascular Graft, by End User USD Million (2018-2023)
  • Table 39. South Korea Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 40. South Korea Vascular Graft, by Indication USD Million (2018-2023)
  • Table 41. South Korea Vascular Graft, by End User USD Million (2018-2023)
  • Table 42. Taiwan Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 43. Taiwan Vascular Graft, by Indication USD Million (2018-2023)
  • Table 44. Taiwan Vascular Graft, by End User USD Million (2018-2023)
  • Table 45. Australia Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 46. Australia Vascular Graft, by Indication USD Million (2018-2023)
  • Table 47. Australia Vascular Graft, by End User USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Vascular Graft, by Indication USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Vascular Graft, by End User USD Million (2018-2023)
  • Table 51. Europe Vascular Graft, by Country USD Million (2018-2023)
  • Table 52. Europe Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 53. Europe Vascular Graft, by Indication USD Million (2018-2023)
  • Table 54. Europe Vascular Graft, by End User USD Million (2018-2023)
  • Table 55. Germany Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 56. Germany Vascular Graft, by Indication USD Million (2018-2023)
  • Table 57. Germany Vascular Graft, by End User USD Million (2018-2023)
  • Table 58. France Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 59. France Vascular Graft, by Indication USD Million (2018-2023)
  • Table 60. France Vascular Graft, by End User USD Million (2018-2023)
  • Table 61. Italy Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 62. Italy Vascular Graft, by Indication USD Million (2018-2023)
  • Table 63. Italy Vascular Graft, by End User USD Million (2018-2023)
  • Table 64. United Kingdom Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 65. United Kingdom Vascular Graft, by Indication USD Million (2018-2023)
  • Table 66. United Kingdom Vascular Graft, by End User USD Million (2018-2023)
  • Table 67. Netherlands Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 68. Netherlands Vascular Graft, by Indication USD Million (2018-2023)
  • Table 69. Netherlands Vascular Graft, by End User USD Million (2018-2023)
  • Table 70. Rest of Europe Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 71. Rest of Europe Vascular Graft, by Indication USD Million (2018-2023)
  • Table 72. Rest of Europe Vascular Graft, by End User USD Million (2018-2023)
  • Table 73. MEA Vascular Graft, by Country USD Million (2018-2023)
  • Table 74. MEA Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 75. MEA Vascular Graft, by Indication USD Million (2018-2023)
  • Table 76. MEA Vascular Graft, by End User USD Million (2018-2023)
  • Table 77. Middle East Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 78. Middle East Vascular Graft, by Indication USD Million (2018-2023)
  • Table 79. Middle East Vascular Graft, by End User USD Million (2018-2023)
  • Table 80. Africa Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 81. Africa Vascular Graft, by Indication USD Million (2018-2023)
  • Table 82. Africa Vascular Graft, by End User USD Million (2018-2023)
  • Table 83. North America Vascular Graft, by Country USD Million (2018-2023)
  • Table 84. North America Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 85. North America Vascular Graft, by Indication USD Million (2018-2023)
  • Table 86. North America Vascular Graft, by End User USD Million (2018-2023)
  • Table 87. United States Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 88. United States Vascular Graft, by Indication USD Million (2018-2023)
  • Table 89. United States Vascular Graft, by End User USD Million (2018-2023)
  • Table 90. Canada Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 91. Canada Vascular Graft, by Indication USD Million (2018-2023)
  • Table 92. Canada Vascular Graft, by End User USD Million (2018-2023)
  • Table 93. Mexico Vascular Graft, by Raw Material USD Million (2018-2023)
  • Table 94. Mexico Vascular Graft, by Indication USD Million (2018-2023)
  • Table 95. Mexico Vascular Graft, by End User USD Million (2018-2023)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Vascular Graft: by Raw Material(USD Million)
  • Table 107. Vascular Graft Polyester , by Region USD Million (2025-2030)
  • Table 108. Vascular Graft EPTFE , by Region USD Million (2025-2030)
  • Table 109. Vascular Graft Polyurethane , by Region USD Million (2025-2030)
  • Table 110. Vascular Graft Biosyntheti , by Region USD Million (2025-2030)
  • Table 111. Vascular Graft: by Indication(USD Million)
  • Table 112. Vascular Graft EVAR (Abdominal Aneurysm Repair & Thoracic Aneurysm0 , by Region USD Million (2025-2030)
  • Table 113. Vascular Graft Peripheral Vascular Repair , by Region USD Million (2025-2030)
  • Table 114. Vascular Graft Hemodialysis Access , by Region USD Million (2025-2030)
  • Table 115. Vascular Graft: by End User(USD Million)
  • Table 116. Vascular Graft Hospital , by Region USD Million (2025-2030)
  • Table 117. Vascular Graft Ambulatory Surgery Center , by Region USD Million (2025-2030)
  • Table 118. South America Vascular Graft, by Country USD Million (2025-2030)
  • Table 119. South America Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 120. South America Vascular Graft, by Indication USD Million (2025-2030)
  • Table 121. South America Vascular Graft, by End User USD Million (2025-2030)
  • Table 122. Brazil Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 123. Brazil Vascular Graft, by Indication USD Million (2025-2030)
  • Table 124. Brazil Vascular Graft, by End User USD Million (2025-2030)
  • Table 125. Argentina Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 126. Argentina Vascular Graft, by Indication USD Million (2025-2030)
  • Table 127. Argentina Vascular Graft, by End User USD Million (2025-2030)
  • Table 128. Rest of South America Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 129. Rest of South America Vascular Graft, by Indication USD Million (2025-2030)
  • Table 130. Rest of South America Vascular Graft, by End User USD Million (2025-2030)
  • Table 131. Asia Pacific Vascular Graft, by Country USD Million (2025-2030)
  • Table 132. Asia Pacific Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 133. Asia Pacific Vascular Graft, by Indication USD Million (2025-2030)
  • Table 134. Asia Pacific Vascular Graft, by End User USD Million (2025-2030)
  • Table 135. China Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 136. China Vascular Graft, by Indication USD Million (2025-2030)
  • Table 137. China Vascular Graft, by End User USD Million (2025-2030)
  • Table 138. Japan Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 139. Japan Vascular Graft, by Indication USD Million (2025-2030)
  • Table 140. Japan Vascular Graft, by End User USD Million (2025-2030)
  • Table 141. India Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 142. India Vascular Graft, by Indication USD Million (2025-2030)
  • Table 143. India Vascular Graft, by End User USD Million (2025-2030)
  • Table 144. South Korea Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 145. South Korea Vascular Graft, by Indication USD Million (2025-2030)
  • Table 146. South Korea Vascular Graft, by End User USD Million (2025-2030)
  • Table 147. Taiwan Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 148. Taiwan Vascular Graft, by Indication USD Million (2025-2030)
  • Table 149. Taiwan Vascular Graft, by End User USD Million (2025-2030)
  • Table 150. Australia Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 151. Australia Vascular Graft, by Indication USD Million (2025-2030)
  • Table 152. Australia Vascular Graft, by End User USD Million (2025-2030)
  • Table 153. Rest of Asia-Pacific Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 154. Rest of Asia-Pacific Vascular Graft, by Indication USD Million (2025-2030)
  • Table 155. Rest of Asia-Pacific Vascular Graft, by End User USD Million (2025-2030)
  • Table 156. Europe Vascular Graft, by Country USD Million (2025-2030)
  • Table 157. Europe Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 158. Europe Vascular Graft, by Indication USD Million (2025-2030)
  • Table 159. Europe Vascular Graft, by End User USD Million (2025-2030)
  • Table 160. Germany Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 161. Germany Vascular Graft, by Indication USD Million (2025-2030)
  • Table 162. Germany Vascular Graft, by End User USD Million (2025-2030)
  • Table 163. France Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 164. France Vascular Graft, by Indication USD Million (2025-2030)
  • Table 165. France Vascular Graft, by End User USD Million (2025-2030)
  • Table 166. Italy Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 167. Italy Vascular Graft, by Indication USD Million (2025-2030)
  • Table 168. Italy Vascular Graft, by End User USD Million (2025-2030)
  • Table 169. United Kingdom Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 170. United Kingdom Vascular Graft, by Indication USD Million (2025-2030)
  • Table 171. United Kingdom Vascular Graft, by End User USD Million (2025-2030)
  • Table 172. Netherlands Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 173. Netherlands Vascular Graft, by Indication USD Million (2025-2030)
  • Table 174. Netherlands Vascular Graft, by End User USD Million (2025-2030)
  • Table 175. Rest of Europe Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 176. Rest of Europe Vascular Graft, by Indication USD Million (2025-2030)
  • Table 177. Rest of Europe Vascular Graft, by End User USD Million (2025-2030)
  • Table 178. MEA Vascular Graft, by Country USD Million (2025-2030)
  • Table 179. MEA Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 180. MEA Vascular Graft, by Indication USD Million (2025-2030)
  • Table 181. MEA Vascular Graft, by End User USD Million (2025-2030)
  • Table 182. Middle East Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 183. Middle East Vascular Graft, by Indication USD Million (2025-2030)
  • Table 184. Middle East Vascular Graft, by End User USD Million (2025-2030)
  • Table 185. Africa Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 186. Africa Vascular Graft, by Indication USD Million (2025-2030)
  • Table 187. Africa Vascular Graft, by End User USD Million (2025-2030)
  • Table 188. North America Vascular Graft, by Country USD Million (2025-2030)
  • Table 189. North America Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 190. North America Vascular Graft, by Indication USD Million (2025-2030)
  • Table 191. North America Vascular Graft, by End User USD Million (2025-2030)
  • Table 192. United States Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 193. United States Vascular Graft, by Indication USD Million (2025-2030)
  • Table 194. United States Vascular Graft, by End User USD Million (2025-2030)
  • Table 195. Canada Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 196. Canada Vascular Graft, by Indication USD Million (2025-2030)
  • Table 197. Canada Vascular Graft, by End User USD Million (2025-2030)
  • Table 198. Mexico Vascular Graft, by Raw Material USD Million (2025-2030)
  • Table 199. Mexico Vascular Graft, by Indication USD Million (2025-2030)
  • Table 200. Mexico Vascular Graft, by End User USD Million (2025-2030)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vascular Graft: by Raw Material USD Million (2018-2023)
  • Figure 5. Global Vascular Graft: by Indication USD Million (2018-2023)
  • Figure 6. Global Vascular Graft: by End User USD Million (2018-2023)
  • Figure 7. South America Vascular Graft Share (%), by Country
  • Figure 8. Asia Pacific Vascular Graft Share (%), by Country
  • Figure 9. Europe Vascular Graft Share (%), by Country
  • Figure 10. MEA Vascular Graft Share (%), by Country
  • Figure 11. North America Vascular Graft Share (%), by Country
  • Figure 12. Global Vascular Graft share by Players 2023 (%)
  • Figure 13. Global Vascular Graft share by Players (Top 3) 2023(%)
  • Figure 14. Global Vascular Graft share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 17. B. Braun (Germany) Revenue: by Geography 2023
  • Figure 18. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 19. Medtronic (Ireland) Revenue: by Geography 2023
  • Figure 20. C. R. Bard (United States) Revenue, Net Income and Gross profit
  • Figure 21. C. R. Bard (United States) Revenue: by Geography 2023
  • Figure 22. LeMaitre Vascular (United States) Revenue, Net Income and Gross profit
  • Figure 23. LeMaitre Vascular (United States) Revenue: by Geography 2023
  • Figure 24. Cardinal Health (United States) Revenue, Net Income and Gross profit
  • Figure 25. Cardinal Health (United States) Revenue: by Geography 2023
  • Figure 26. Maquet (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Maquet (Germany) Revenue: by Geography 2023
  • Figure 28. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 29. Cook Medical (United States) Revenue: by Geography 2023
  • Figure 30. Endologix (United States) Revenue, Net Income and Gross profit
  • Figure 31. Endologix (United States) Revenue: by Geography 2023
  • Figure 32. Gore Medical (United States) Revenue, Net Income and Gross profit
  • Figure 33. Gore Medical (United States) Revenue: by Geography 2023
  • Figure 34. Terumo (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Terumo (Japan) Revenue: by Geography 2023
  • Figure 36. Global Vascular Graft: by Raw Material USD Million (2025-2030)
  • Figure 37. Global Vascular Graft: by Indication USD Million (2025-2030)
  • Figure 38. Global Vascular Graft: by End User USD Million (2025-2030)
  • Figure 39. South America Vascular Graft Share (%), by Country
  • Figure 40. Asia Pacific Vascular Graft Share (%), by Country
  • Figure 41. Europe Vascular Graft Share (%), by Country
  • Figure 42. MEA Vascular Graft Share (%), by Country
  • Figure 43. North America Vascular Graft Share (%), by Country
List of companies from research coverage that are profiled in the study
  • B. Braun (Germany)
  • Medtronic (Ireland)
  • C. R. Bard (United States)
  • LeMaitre Vascular (United States)
  • Cardinal Health (United States)
  • Maquet (Germany)
  • Cook Medical (United States)
  • Endologix (United States)
  • Gore Medical (United States)
  • Terumo (Japan)
Additional players considered in the study are as follows:
Getinge Group , Bard , JUNKEN MEDICAL , Shanghai Suokang , Shanghai Chest Medical
Select User Access Type

Key Highlights of Report


Jan 2024 219 Pages 69 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Vascular Graft Quantitative research analysis
Vascular Graft Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as B. Braun (Germany), Medtronic (Ireland), C. R. Bard (United States), LeMaitre Vascular (United States), Cardinal Health (United States), Maquet (Germany), Cook Medical (United States), Endologix (United States), Gore Medical (United States) and Terumo (Japan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Development of Biosynthetic Vascular Graft" is seen as one of major influencing trends for Vascular Graft Market during projected period 2023-2030.
The Vascular Graft market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Vascular Graft Report?

Have a Query? Click Here

Other Related Reports

Hirudin Comprehensive Study by Type (Natural Hirudin, Recombinant Hirudin), Disease Indication (Heparin-Induced Thrombocytopenia, Unstable Angina, Tumors, Others) Players and Region - Global Market O...
$ 3500
Prednisolone Acetate Comprehensive Study by Type (Prednisolone Acetate Tablet, Prednisolone Acetate Liquid, Prednisolone Acetate Emulsifiable Paste), Application (Hypersensitivity Disease, Autoimmune...
$ 3450
Sacral Nerve Stimulation Comprehensive Study by Type (Implantable, External), Application (Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure, Others), End User (Hospitals, Ambulat...
$ 3350
Scleroderma Diagnostics and Therapeutics Comprehensive Study by Application (Hospitals, Clinics), Diagnostics (Antibodies Tests/Blood Tests, Capillaroscopy, Cardiac Diagnosis, Gastrointestinal Diagno...
$ 3750
Renal Anemia Therapeutics Comprehensive Study by Type (DS-1093, EPO-018B, FG-2216, JTZ-951, MDGN-201), Application (Hospital, Research Center, Clinic), Mode of Administration (Oral, Parenteral) Playe...
$ 3500
Antihemophilic Factor Comprehensive Study by Type (Plasma Derived, Plasma Derived/VWF Complex, Recombinant Antihemophilic Factor), Distribution (Hospital Pharmacies, Retail Pharmacies, Online Pharmac...
$ 3350